BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, En H, Yang L, Zhang Y, Sun B, Gao J. miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib. Onco Targets Ther 2019;12:6825-38. [PMID: 31686840 DOI: 10.2147/OTT.S215145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu Z, Han M, Meng N, Luo J, Fu R. lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma. Oxid Med Cell Longev 2021;2021:9969449. [PMID: 34422217 DOI: 10.1155/2021/9969449] [Reference Citation Analysis]
2 Gao Y, Liu P, Shi R. Anlotinib as a molecular targeted therapy for tumors. Oncol Lett 2020;20:1001-14. [PMID: 32724339 DOI: 10.3892/ol.2020.11685] [Cited by in Crossref: 5] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
3 Wang J, Ding W, Xu Y, Tao E, Mo M, Xu W, Cai X, Chen X, Yuan J, Wu X. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1. Aging (Albany NY) 2020;12:4558-72. [PMID: 32163372 DOI: 10.18632/aging.102911] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]